Today’s biopharma needs more than just accurate data for their trials; they need bioanalysis partners who have been diligently building the future of drug development. At IQVIA Laboratories Biosciences, we’ve significantly invested in a digital transformation to become a paperless laboratory, which is now positively transforming how our GLP bioanalytical labs operate by leaps and bounds.
This insightful webinar explores how our evolving paperless lab infrastructure enhances data integrity, delivers real-time QC, and drives measurable efficiency ensuring your outsourced bioanalytical projects are inspection-ready and future-enabled.
Complete the form below to access the On-Demand Webinar.
Related Insights
ADME Services
Accelerating your drug discovery, preclinical and clinical programs
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Bioanalytical Automation of Samples
Taking an assay from bench to an automated platform
Developing Assays for Novel Drugs
Current science regarding hybrid assays, why they are considered the next "big thing," the technical challenges, and the regulatory impact of these assays.
Strategies for Effective Neutralizing Cell Based Assays in Early Immunogenicity Risk Assessment
Quantitative Assays for Peptides using LC-MS
Quantitative high-throughput analysis of peptide therapeutics and biomarkers to regulated bioanalytical standards
Hybrid Assays for Protein Bioanalysis
Assays and Why Are They Essential for Protein Bioanalysis?
Bioanalysis for Immuno Oncology with Mike Brown
I-O clinical development podcast series
IQVIA Laboratories Corporate Brochure
A global drug discovery and development laboratory services organization
Assay Development for Large-Scale Clinical Studies
Bioanalytical expertise to support large-scale, international studies
